Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Mouse Anti-Bcl-xL-UNLB (7B2.5)

Cat. No.:
10030-01
Purified Anti-Bcl-xL antibody for use in flow cytometry, immunohistochemistry / immunocytochemistry, ELISA, western blot, and immunoprecipitation assays.
$325.00
Size Price (USD) Quantity
0.1 mg $325.00
More Information
Clone 7B2.5
Isotype Mouse (BALB/c) IgG3κ
Isotype Control Mouse IgG3-UNLB (B10)
Specificity Human/Mouse/Rat/Rhesus Bcl-xL
Alternative Names Apoptosis regulator Bcl-X, Bcl-2-like 1 protein, BCL2L1
Description Bcl-xL is a 29 kDa member of the Bcl-2 family of proteins involved in regulation of programmed cell death, or apoptosis. It is found in both soluble and membrane fractions of cellular lysates. Like Bcl-2, Bcl-xL has been demonstrated to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. While formation of heterodimers with the apoptosis-enhancing protein Bax does not block the apoptosis-suppressing property of Bcl-xL, heterodimerization with Bad effectively inhibits the protective function of Bcl-xL.
Immunogen Recombinant human Bcl-xS
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Monoclonal
Concentration 0.1 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications Flow Cytometry – Quality tested 2-25
Immunohistochemistry-Paraffin Sections – Reported in literature 26
Immunocytochemistry – Reported in literature 27
Western Blot – Reported in literature 1,28-30
Immunoprecipitation – Reported in literature 30,31
ELISA – Reported in literature 1

RRID Number AB_2794101
Gene ID 598 (Human)
12048 (Mouse)
24888 (Rat)
713035 (Rhesus)
Gene ID Symbol BCL2L1 (Human)
Bcl2l1 (Mouse)
Bcl2l1 (Rat)
BCL2L1 (Rhesus)
Gene ID Aliases BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52; Bcl(X)L; Bcl-XL; Bcl2l; BclX; bcl-x; bcl2-L-1; Bcl-xl; Bclx; bcl-X; EGK_02534
UniProt ID Q07817 (Human)
Q64373 (Mouse)
P53563 (Rat)
UniProt Name B2CL1_HUMAN (Human)
B2CL1_MOUSE (Mouse)
B2CL1_RAT (Rat)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 1995;3:87-98. (Immunogen, WB, ELISA)
  2. 2. Hettmann T, DiDonato J, Karin M, Leiden JM. An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis. J Exp Med. 1999;189:145-57. (FC)
  3. 3. Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med. 2001;7:913-9. (FC)
  4. 4. Kreisel D, Krupnick AS, Balsara KR, Riha M, Gelman AE, Popma SH, et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol. 2002;169:6154-61. (FC)
  5. 5. Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, et al. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. J Leukoc Biol. 2002;72:83-92. (FC)
  6. 6. Petrovas C, Mueller YM, Dimitriou ID, Bojczuk PM, Mounzer KC, Witek J, et al. HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol. 2004;172:4444-53. (FC)
  7. 7. Wu LX, La Rose J, Chen L, Neale C, Mak T, Okkenhaug K, et al. CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway. J Immunol. 2005;174:180-94. (FC)
  8. 8. Vigorito E, Gambardella L, Colucci F, McAdam S, Turner M. Vav proteins regulate peripheral B-cell survival. Blood. 2005;106:2391-8. (FC)
  9. 9. Homann D, Dummer W, Wolfe T, Rodrigo E, Theofilopoulos AN, Oldstone MB, et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol. 2006;80:270-80. (FC)
  10. 10. Huddleston CA, Weinberg AD, Parker DC. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells. Eur J Immunol. 2006;36:1093-103. (FC)
  11. 11. Yadav A, Pati S, Nyugen A, Barabitskaja O, Mondal P, Anderson M, et al. HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation. Virology. 2006;353:357-65. (FC)
  12. 12. Mueller YM, Petrovas C, Do DH, Altork SR, Fischer-Smith T, Rappaport J, et al. Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects. J Virol. 2007;81:10861-8. (FC, Rhesus Reactivity)
  13. 13. Li S, Wang L, Zhao C, Li L, Peng J, Hou M. CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol. 2007;139:605-11. (FC)
  14. 14. Mueller KL, Thomas MS, Burbach BJ, Peterson EJ, Shimizu Y. Adhesion and degranulation-promoting adapter protein (ADAP) positively regulates T cell sensitivity to antigen and T cell survival. J Immunol. 2007;179:3559-69. (FC)
  15. 15. Hossain MZ, Yu Q, Xu M, Sen JM. ICAT expression disrupts β-catenin-TCF interactions and impairs survival of thymocytes and activated mature T cells. Int Immunol. 2008;20:925-35. (FC)
  16. 16. Barron L, Knoechel B, Lohr J, Abbas AK. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J Immunol. 2008;180:2762-6. (FC)
  17. 17. Yang L, Wang L, Zhao C, Zhu X, Hou Y, Peng J, et al. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia. Blood. 2010;116:4307-16. (FC)
  18. 18. Osborne LC, Duthie KA, Seo JH, Gascoyne RD, Abraham N. Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development. Oncogene. 2010;29:3854-64. (FC)
  19. 19. Chang C, Lai Y, Hou M, Huang P, Liao N. IL-15Rα of radiation-resistant cells is necessary and sufficient for thymic invariant NKT cell survival and functional maturation. J Immunol. 2011;187:1235-42. (FC)
  20. 20. Gross AJ, Proekt I, DeFranco AL. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur J Immunol. 2011;41:3645-55. (FC)
  21. 21. Yao S, Zhu Y, Zhu G, Augustine M, Zheng L, Goode DJ, et al. B7-h2 is a costimulatory ligand for CD28 in human. Immunity. 2011;34:729-40. (FC)
  22. 22. Burns JC, Corbo E, Degen J, Gohil M, Anterasian C, Schraven B, et al. The SLP-76 Src homology 2 domain is required for T cell development and activation. J Immunol. 2011;187:4459-66. (FC)
  23. 23. Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol. 2011;187:6335-45. (FC)
  24. 24. Zhang T, Wu M, Sentman CL. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo. J Immuno. 2012;189:2290-9. (FC)
  25. 25. Min Y, Wang C, Li X, Hou Y, Qiu J, Ma J. Participation of BAFF receptors in the pathogenesis of immune thrombosytopenia(ITP). J Thromb Haemost. 2016 Jan 8. doi: 10.1111/jth.13246. [Epub ahead of print]. (FC)
  26. 26. Hartmann K, Artuc M, Baldus SE, Zirbes TK, Hermes B, Thiele J, et al. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol. 2003;163:819-26. (IHC-PS)
  27. 27. Yamaguchi N, Kieba IR, Korostoff J, Howard PS, Shenker BJ, Lally ET. Maintenance of oxidative phosphorylation protects cells from Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Cell Microbiol. 2001;3:811-23. (ICC)
  28. 28. Kim H, Rafiuddin-Shah M, Tu H, Jeffers JR, Zambetti GP, Hsieh JJ, et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol. 2006;8:1348-58. (WB)
  29. 29. Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-xL. Biotechnol Bioeng. 2008;101:567-78. (WB)
  30. 30. Broustas CG, Ross JS, Yang Q, Sheehan CE, Riggins R, Noone A, et al. The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clin Cancer Res. 2010;16:2939-48. (WB, IP)
  31. 31. Passer BJ, Pellegrini L, Vito P, Ganjei JK, D'Adamio L. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-XL. A potential role in modulating the threshold of cell death. J Biol Chem. 1999;274:24007-13. (IP)
See All References